Search
very late antigen 6 (VLA-6, integrin alpha-6/beta-1)
Function:
- platelet laminin receptor
Related
platelet
General
CD49 or Very Late Antigen (VLA)
Properties
COMPARTMENT: plasma membrane
CELL: T-cell
MOTIF: focal adhesion site
glycosylation site
membrane region
SUBUNITS: integrin alpha-6
MOTIF: signal sequence {1-23}
FG-GAP {42-79}
MOTIF: N-glycosylation site {N78}
cysteine residue {C86}
MODIFICATION: cysteine residue {C94}
cysteine residue {C94}
MODIFICATION: cysteine residue {C86}
FG-GAP {113-145}
MOTIF: cysteine residue {C131}
MODIFICATION: cysteine residue {C154}
cysteine residue {C154}
MODIFICATION: cysteine residue {C131}
cysteine residue {C175}
MODIFICATION: cysteine residue {C188}
FG-GAP {185-217}
MOTIF: cysteine residue {C188}
MODIFICATION: cysteine residue {C175}
N-glycosylation site {N223}
FG-GAP {295-331}
MOTIF: N-glycosylation site {N323}
FG-GAP {353-391}
MOTIF: Ca+2-binding site
SITE: 363-371
N-glycosylation site {N409}
FG-GAP {414-450}
MOTIF: Ca+2-binding site
SITE: 425-433
FG-GAP {469-509}
MOTIF: Ca+2-binding site
SITE: 480-488
cysteine residue {C528}
MODIFICATION: cysteine residue {C535}
cysteine residue {C535}
MODIFICATION: cysteine residue {C528}
cysteine residue {C541}
MODIFICATION: cysteine residue {C601}
kxgffkr
NAME: kxgffkr
SITE: cytoplasmic domain
FOR-BINDING-OF: calreticulin
FORM: kxgffkr
cysteine residue {C601}
MODIFICATION: cysteine residue {C541}
cysteine residue {C665}
MODIFICATION: cysteine residue {C671}
cysteine residue {C671}
MODIFICATION: cysteine residue {C665}
cysteine residue {C765}
MODIFICATION: cysteine residue {C776}
N-glycosylation site {N770}
cysteine residue {C776}
MODIFICATION: cysteine residue {C765}
N-glycosylation site {N787}
cysteine residue {C920}
MODIFICATION: cysteine residue {C-INTERCHAIN}
N-glycosylation site {N930}
N-glycosylation site {N966}
cysteine residue {C973}
MODIFICATION: cysteine residue {C978}
cysteine residue {C978}
MODIFICATION: cysteine residue {C973}
N-glycosylation site {N997}
transmembrane domain {1051-1076}
HPS5 interaction {1077-1083}
MOTIF: GFFKR {1079-1083}
integrin-beta 1
MOTIF: signal sequence {1-20}
cysteine residue {C27}
MODIFICATION: cysteine residue {C464}
cysteine residue {C35}
MODIFICATION: cysteine residue {C45}
cysteine residue {C38}
MODIFICATION: cysteine residue {C75}
cysteine residue {C45}
MODIFICATION: cysteine residue {C35}
cysteine residue {C48}
MODIFICATION: cysteine residue {C64}
N-glycosylation site {N50}
cysteine residue {C64}
MODIFICATION: cysteine residue {C48}
cysteine residue {C75}
MODIFICATION: cysteine residue {C38}
N-glycosylation site {N94}
N-glycosylation site {N97}
VWFA domain {140-378}
MOTIF: cysteine residue {C207}
MODIFICATION: cysteine residue {C213}
N-glycosylation site {N212}
cysteine residue {C213}
MODIFICATION: cysteine residue {C207}
cysteine residue {C261}
MODIFICATION: cysteine residue {C301}
N-glycosylation site {N269}
cysteine residue {C301}
MODIFICATION: cysteine residue {C261}
N-glycosylation site {N363}
cysteine residue {C401}
MODIFICATION: cysteine residue {C415}
N-glycosylation site {N406}
cysteine residue {C415}
MODIFICATION: cysteine residue {C401}
N-glycosylation site {N417}
cysteine residue {C435}
MODIFICATION: cysteine residue {C691}
cysteine residue {C462}
MODIFICATION: cysteine residue {C466}
cysteine residue {C464}
MODIFICATION: cysteine residue {C27}
Cysteine-rich tandem repeats {466-635}
MOTIF: I {466-515}
cysteine residue {C466}
MODIFICATION: cysteine residue {C462}
cysteine residue {C477}
MODIFICATION: cysteine residue {C489}
N-glycosylation site {N481}
cysteine residue {C486}
MODIFICATION: cysteine residue {C525}
cysteine residue {C489}
MODIFICATION: cysteine residue {C477}
cysteine residue {C491}
MODIFICATION: cysteine residue {C500}
cysteine residue {C500}
MODIFICATION: cysteine residue {C491}
cysteine residue {C502}
MODIFICATION: cysteine residue {C516}
II {516-559}
cysteine residue {C516}
MODIFICATION: cysteine residue {C502}
N-glycosylation site {N520}
cysteine residue {C525}
MODIFICATION: cysteine residue {C486}
cysteine residue {C531}
MODIFICATION: cysteine residue {C536}
cysteine residue {C533}
MODIFICATION: cysteine residue {C568}
cysteine residue {C536}
MODIFICATION: cysteine residue {C531}
cysteine residue {C538}
MODIFICATION: cysteine residue {C553}
cysteine residue {C553}
MODIFICATION: cysteine residue {C538}
cysteine residue {C555}
MODIFICATION: cysteine residue {C560}
III {560-598}
cysteine residue {C560}
MODIFICATION: cysteine residue {C555}
cysteine residue {C568}
MODIFICATION: cysteine residue {C533}
cysteine residue {C574}
MODIFICATION: cysteine residue {C579}
cysteine residue {C576}
MODIFICATION: cysteine residue {C607}
cysteine residue {C579}
MODIFICATION: cysteine residue {C574}
cysteine residue {C581}
MODIFICATION: cysteine residue {C590}
N-glycosylation site {N584}
cysteine residue {C590}
MODIFICATION: cysteine residue {C581}
cysteine residue {C592}
MODIFICATION: cysteine residue {C599}
IV {599-635}
cysteine residue {C599}
MODIFICATION: cysteine residue {C592}
cysteine residue {C607}
MODIFICATION: cysteine residue {C576}
cysteine residue {C613}
MODIFICATION: cysteine residue {C618}
cysteine residue {C615}
MODIFICATION: cysteine residue {C661}
cysteine residue {C618}
MODIFICATION: cysteine residue {C613}
cysteine residue {C620}
MODIFICATION: cysteine residue {C630}
cysteine residue {C630}
MODIFICATION: cysteine residue {C620}
cysteine residue {C633}
MODIFICATION: cysteine residue {C636}
cysteine residue {C636}
MODIFICATION: cysteine residue {C633}
cysteine residue {C640}
MODIFICATION: cysteine residue {C649}
cysteine residue {C646}
MODIFICATION: cysteine residue {C723}
cysteine residue {C649}
MODIFICATION: cysteine residue {C640}
cysteine residue {C661}
MODIFICATION: cysteine residue {C615}
cysteine residue {C665}
MODIFICATION: cysteine residue {C699}
N-glycosylation site {N669}
cysteine residue {C691}
MODIFICATION: cysteine residue {C435}
cysteine residue {C699}
MODIFICATION: cysteine residue {C665}
cysteine residue {C723}
MODIFICATION: cysteine residue {C646}
transmembrane domain {729-751}
Tyr phosphorylation site {Y783}
References
PROSITE :accession PS00242
Components
CD29; integrin-beta 1; fibronectin receptor beta; platelet glycoprotein IIa; VLA-4 beta (ITGB1, FNRB, MDF2, MSK12)
CD49f (integrin alpha-6, integrin alpha-F, ITGA6)